1302P MET×MET bispecific antibody davutamig (REGN5093) for MET-altered advanced non-small cell lung cancer (aNSCLC): Update from a first-in-human (FIH) study
2024 · Annals of Oncology · 4 citations
https://doi.org/10.1016/j.annonc.2024.08.1359
M
M-J. Ahn
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
10
Citations
2
h-index
0
i10-index
M-J. Ahn is an academic researcher from Samsung Medical Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Lung Cancer Diagnosis and Treatment. The author has an h-index of 2, co-authored 10 publications.
Papers by this author
works692P Landscape of co-occurring OncoKB tier 1/2 alterations in EGFR-mutated lung adenocarcinoma (LUAD) harboring common driver alterations using circulating tumor DNA (ctDNA) next generation sequencing (NGS) in Asia and the Middle East (AME)
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.10.725
PT2.12.03 Zongertinib in Patients With Previously Treated HER2-Mutant NSCLC and Brain Metastases at Baseline: Beamion LUNG-1
2025 · Journal of Thoracic Oncology · 0 citations
https://doi.org/10.1016/j.jtho.2025.09.1159
2760MO Intracranial activity of ifinatamab deruxtecan (I-DXd) in patients (pts) with extensive-stage (ES) small cell lung cancer (SCLC) and baseline (BL) brain metastases (BM): Primary analysis of IDeate-Lung01
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.08.3371
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat